Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: MDR-TB

Posted on March 14, 2020March 17, 2020

Trial shows success in treating drug-resistant TB

A 26-week treatment of 109 XDR-TB and MDR-TB patients with three oral drugs — bedaquiline, pretomanid, and linezolid — showed 90% success rate. There were seven deaths and two had…

Continue Reading
Posted on August 19, 2019

Pretomanid: XDR-TB may soon become easily treatable

Though the total number of people with XDR-TB and treatment intolerant or non-responsive MDR-TB who will require the new anti-TB drug Pretomanid may not be high, these are people who…

Continue Reading
Posted on August 16, 2019August 18, 2019

Explainer: What makes the new drug-resistant TB medicine Pretomanid promising

When used in combination with bedaquiline and linezolid, the newly approved pretomanid drug for MDR-TB and XDR-TB had an overall treatment success rate of about 90%. Besides better effectiveness, the…

Continue Reading
Posted on March 21, 2019March 21, 2019

Majority of MDR-TB cases in India due to direct transmission: Lancet

While India has set a highly ambitious target of “eliminating TB by 2025”, modelling studies published today say incidence and mortality will reduce by just 57% and 72% respectively by…

Continue Reading
Posted on September 8, 2018September 8, 2018

Small DNA-based inhibitor blocks entry of TB bacteria into host cells

A team of researchers from three institutions in India has used aptamer-based inhibitor that binds to the HupB protein found on TB bacteria cell surface to significantly inhibit the entry…

Continue Reading
Posted on September 4, 2018September 4, 2018

MDR-TB treatment gets a boost with the inclusion of bedaquiline in the fully-oral regimen

In a “rapid communication”, WHO has informed all member States to take “immediate steps” to ensure that all injectables are replaced with a fully-oral regimen that includes bedaquiline to treat…

Continue Reading
Posted on January 16, 2018January 16, 2018

WHO revises advice on use of delamanid drug in MDR-TB patients

In a Phase III trial, delamanid drug was found to be safe but the cure rate and mortality rate were not different between the group that received the delamanid drug…

Continue Reading
Posted on November 2, 2017November 2, 2017

A glimmer of hope as India’s war on TB gets more funding

There is a glimmer of hope with India registering a slight drop in the number of new tuberculosis cases and TB deaths in 2016 compared with 2015. From an estimated…

Continue Reading

Posts navigation

Page 1 Page 2 … Page 7 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,580 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial January 13, 2021
  • New challenges in conducting COVID-19 vaccine trials in India January 9, 2021
  • I would not take Covaxin without efficacy data: Gagandeep Kang January 8, 2021

Most Read Posts

  • Vaccine dilemma: To take or not to take Covaxin
  • Indian scientists divided over restricted use approval for Covaxin
  • Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial
  • I would not take Covaxin without efficacy data: Gagandeep Kang
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • Sadhguru Jaggi Vasudev, stop spreading vaccine misinformation
  • No correlation between Ct values of PCR test and COVID-19 severity
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,580 other followers

Archives

Cancel